(408) 747-0185

TIF-IA Antibody

Catalog No : B8433
  • Applications
    WB, ELISA
  • Reactivity
    Human
  • Size
    100ul
  • Price
    $295.00
Anti-TIF-IA Antibody detects endogenous levels of total TIF-IA protein. Validated for WB and ELISA. Reactive for Human. AssayBiotechnology an original antibody manufacturer.
Details
  • Product Name
    TIF-IA Antibody
  • Catalog No
    B8433
  • Storage/Stability
    Stable at -20°C for at least 1 year.
  • Applications
    WB, ELISA
  • Clonality
    Polyclonal
  • Host Species
    Rabbit
  • Reactivity
    Human
  • Application Dilutions
    WB: 1:500~1:1000 ELISA: 1:1000
  • Database Links
    Gene ID: 54700, Swiss-Prot #: Q9NYV6, OMIM #: 605121, Unigene #: Hs.460078
  • Immunogen
    The antiserum was produced against synthesized peptide derived from human TIF-IA.
  • Immunogen Range
    602-651
  • MW
    74 kDa
  • NCBI Gene Symbol
    RRN3
  • Physical Form
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
  • Purification
    The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
  • Specificity
    TIF-IA Antibody detects endogenous levels of total TIF-IA protein.
  • Synonyms
    RNA polymerase I-specific transcription initiation factor RRN3, RRN3, transcription initiation factor IA
  • Target Modification
    Unmodified/Total
Application Images
Western blot analysis of lysates from HeLa cells, treated with calyculinA 50ng/ml 30', using TIF-IA Antibody. The lane on the right is blocked with the synthesized peptide.
Western blot analysis of 3T3 lysate, antibody was diluted at 1:1000.
Western blot analysis of lysates from HeLa cells, treated with calyculinA 50ng/ml 30', using TIF-IA Antibody. The lane on the right is blocked with the synthesized peptide.
Western blot analysis of 3T3 lysate, antibody was diluted at 1:1000.
References
This product has been referenced in:
  • "Jingyu Chen1; Ian T Lobb1; Pierre Morin1; Sonia M Novo1; James Simpson1; Kathrin Kennerknecht1 Identification of a novel, NF-κB nucleolar stress response pathway Primary Antibody Read more >